Evaluation of HER2 Positivity Based on Clinicopathological Findings in HER2 Borderline Tumors in Iranian Patients with Breast Cancer

BACKGROUND & OBJECTIVE: Human epidermal growth receptor-2 (HER2) gene amplification is an important predictive and prognostic factor in breast cancer treatment. However, the expression of HER2 determined by immunohistochemistry (IHC) is considered as borderline in some cases, and confirmation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Omranipour, Ramesh, Nazarian, Newsha, Alipour, Sadaf, Abdollahi, Alireza, Eslami, Bita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646737/
https://www.ncbi.nlm.nih.gov/pubmed/38024548
http://dx.doi.org/10.30699/IJP.2023.561915.2970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646737/
https://www.ncbi.nlm.nih.gov/pubmed/38024548
http://dx.doi.org/10.30699/IJP.2023.561915.2970

Ejemplares similares